Bibliografía del artículo
1. Centers for Disease Control and Prevention. Epidemiology & Prevention of Vaccine-Preventable Diseases. Atkinson W, Hamborsky J, Wolfe S, eds. 8th ed. Washington DC: Public Health Foundation, 2004.
2. Comité Asesor de Vacunas de la Asociación Española de Pediatría. Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2005. An Pediatr (Barc) 62:158-160, 2005.
3. Farjas Abadía P, Zubizarreta Alberdi R, Louro González A, Suárez Rodríguez B. Manual de Vacunaciones del Adulto. Ed. Casitérides SL; 2003.
4. Grupo de consenso sobre gripe. Asociación española de Vacunología. Conferencia de Consenso sobre Gripe. Ed. Asociación Española de Vacunología; 2005. pp. 64-88.
5. WHO/Europe influenza surveillance (Euro Flu.org): http://www.euroflu.org/cgi-files/bulletin_v2.cgi. http://www.who.int/.
6. Ministerio de Sanidad y Política Social de España. Información sobre la gripe A. http://www.msc.es/profesionales/saludPublica/gripeA/guiasProtocolosInf/.
7. Arístegui J, Farjas P, Domínguez A, y col. Asociación Española de Vacunología. Conferencia consenso sobre gripe. [citado jun 2005]. Disponible en: http://www.aev.es/aev/html/biblio/biblio01.htm
8. Schwarz Chavarri G, Pedrera V, Ortuno López JL, Orozco BD, Gil V, Pastor Climent MA. Influence of physician and physician list characteristics on influenza vaccination rates in older people in a health care area in the community of Valencia, Spain. Aten Primaria 34:336-42, 2004.
9. Mayo ME, Hernández V, Sierra Moros MJ, y col. Evolution of the degrees of influenza vaccine (flu shot) coverage in Spain throughout the 1993-2001 period. Analysis by Autonomous Communities. Rev Esp Salud Pública 78:481-92, 2004.
10. Jiménez-García R, Ariñez-Fernandez MC, Garcia-Carballo M, Hernández-Barrera V, Gil de Miguel A, Carrasco-Garrido P. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine 23:3679-3686, 2005.
11. Guidelines for the Diagnosis and Management of Asthma (EPR-3). Disponible en: http://www.nhlbi.nih.gov/guidelines/asthma/.
12. Cates CJ, Jefferson TO, Rowe BH. Vacunas para la prevención de la gripe en pacientes asmáticos En: La Biblioteca Cochrane Plus, 2008 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com (Traducida de The Cochrane Library, 2008. Issue 3. Chichester, UK: John Wiley & Sons, Ltd.).
13. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 130:397-403, 1999.
14. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A metaanalysis and review of the literature. Ann Intern Med 123:518-27, 1995.
15. Van der Wouden JC, Bueving HJ, Poole P. Preventing influenza: an overview of systematic reviews. Respir Med 99(11):1341-9, 2005.
16. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 125:2011-20, 2004.
17. Malfroot A, Adam G, Ciofu O, y col. European Cystic Fibrosis Society (ECFS) Vaccination Group. Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros 4(2):77-87, 2005.
18. Tan A, Bhalla P, Smyth R. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev 2000(2):CD001753.
19. Melcher L. Recommendations for Influenza and Pneumococcal Vaccinations in People Receiving Chemotherapy. Clinical Oncology 17:12-15, 2005.
20. Earle CC. Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol 21:1161-1166, 2003.
21. World Health Organization. WHO position paper. Wkly Epidemiol Rec 28:230-9, 2002.
22. Torres A, Soler N. Evaluación de la etiología y del abordaje terapéutico de la neumonía adquirida en la comunidad. Med Clin (Barc) 116:179-81, 2001.
23. Mirete Ferrer C, Gutiérrez Rodero F, Rodríguez Díaz JC, Royo García G, Shum Fhunk C, Martín Hidalgo A. Etiología de la neumonía adquirida en la comunidad tratada ambulatoriamente. Utilidad de un protocolo diagnóstico con pruebas microbiológicas convencionales y detección de antígenos de S. pneumoniae y L. pneumophila en orina. Med Clin (Barc) 117:657-9, 2001.
24. Álvarez Gutiérrez FJ, Del Castillo Otero D, García Fernández A, y col. Estudio prospectivo de 221 neumonías adquiridas en la comunidad seguidas de forma ambulatoria. Etiología y evolución clinicorradiológica. Med Clin (Barc) 116:161-6, 2001.
25. Alfageme I, Aspa J, Bello S, y col. Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Área de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR. Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 41:272-89, 2005.
26. Vaqueiro Subirats M, Sampere Valero M, Font Creus B, Serrate Sanmiguel G, Fontanals Aymerich D, Segura Porta F. Bacteriemia neumocócica en pacientes mayores de 65 años. Estudio de 161 casos. Med Clin (Barc) 241-5, 2001.
27. CDC. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49(RR-09):1-38, 2000.
28. Fine MJ, Smith MA, Carson CA, y col. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized trials. Arch Intern Med 154:2666-77, 1994.
29. Hutchinson BG, Oxman A, Shannon H, Lloyd S, Altmayer C, Thomas K. Clinical effectiveness of pneumococcal vaccine. Meta-analysis. Can Fam Physician 45:2381-93, 1999.
30. Moore RA, Wiffen PJ, Lipsky BA. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Family Practice 1:1, 2000.
31. Cornu C, Yzébe D, Leophonte P, Gaillat J, Boissel JP, Cucherat M. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 19:4780-90, 2001.
32. Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 19:353-363, 2004.
33. Leech JA, Gervais A, Ruben FL. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. CMAJ 136:361-365, 1987.
34. Franzen D. Clinical efficacy of pneumococcal vaccination - a prospective study in patients with longstanding emphysema and/or bronchitis. Eur J Med Res 5:537-540, 2000.
35. Alfageme I, Vazquez R, Reyes N, y col. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 61:189-195, 2006.
36. Talbot TR, Hartert TV, Mitchel E, y col. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 352:2082-2090, 2005.
37. Jackson LA, Neuzil KM, Yu O, y col, the Vaccine Safety Datalink. Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults. N Engl J Med 348:1747-1755, 2003.
38. Pachón del Amo I. Calendario de vacunación infantil y Recomendaciones de vacunación en adultos. Inf Ter Sist Nac Salud 28: 81-88, 2004.
39. Vacunación de adultos, 2004. Documento de la Ponencia de Programas y Registro de Vacunaciones. Ministerio de Sanidad y Consumo. Documento Aprobado por la Comisión de Salud Pública, con fecha: 29 de septiembre de 2004.
40. Gómez Marco JJ, Canals Aracil M, González Martínez MC, Antona Casado J, Benito Poveda A. Inmunización: saltos al futuro. Vacunas neumocócicas: problemas y soluciones. Aten Primaria 31:55-60, 2003.
41. Black S, Shinefield H, Fireman B, y col, and the Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 18:187-95, 2000.
42. Eskola J, Kilpi T, Palmu A, y col. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344:403-9, 2001.
43. Direct and Indirect Effects of Routine Vaccination of Children With 7-Valent Pneumococcal Conjugate Vaccine on Incidence of Invasive Pneumococcal Disease United States, 1998-2003. MMWR 54:893-897, 2005.